Illumina, Inc. (NASDAQ: ILMN) and MyOme, a leading genomics innovation and risk modeling company, today announced a collaboration and investment by Illumina into MyOme. The collaboration and investmen ...

Recent industry reports have highlighted past and projected rapid expansion in the DNA diagnostics and genomics markets, driven by liquid biopsies, direct-to-consumer testing, and personalized ...

Illumina, Commercial Metals and Newmont stand out as brokers boost ratings amid inflation concerns and shifting economic signals.

With the MiSeq™ i100 Series, Illumina continues to set the highest standards.Advancements in system design, sequencing chemistry, and data analysis deliverthe simplest, fastest benchtop sequencing and ...

The next generation sequencing market offers significant opportunities by enhancing the diagnosis and treatment of chronic ...

The universal features that define genomic regions acting as replication origins remain unclear. In this study, we mapped a set of origins in Trypanosoma brucei using stranded short nascent strand ...

The 24th HUPO World Congress showed a field growing beyond mass spectrometry and starting to think in terms of impact of its ecosystems.

The global genomics market is projected to expand by 15-17% by 2029. Key factors driving this growth include the increasing ...

Quest Diagnostics appoints new leader for Blueprint. Juhana Rauramo is in as vice president and general manager for Blueprint ...

In this edition of the biotech bi-weekly, we highlight the latest exciting product launches, partnerships and company events.

Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced a series ...

Next Gen Stats continues to evolve how we can quantify what we see on Sundays (and Mondays, Thursdays, an occasional Friday or Saturday and some other days). Senior NFL Researcher Tony ...